Related Experiment Video
Updated: Aug 11, 2026

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
Published on: May 21, 2017
Late incidence and determinants of stroke after aortic and mitral valve replacement
Marc Ruel1, Roy G Masters, Fraser D Rubens
1Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ontario, Canada. mruel@ottawaheart.ca
Insights
Patients with prosthetic valves face a significant risk of embolic stroke, with approximately 20% experiencing one within 15 years. Modifiable factors like avoiding smoking and timely mitral valve surgery can reduce this risk.
Area of Science:
- Cardiology
- Vascular Surgery
- Clinical Epidemiology
Background:
- Stroke is a serious complication for patients with prosthetic heart valves.
- Characterizing the long-term occurrence of stroke in this population from a large cohort is needed.
Purpose of the Study:
- To investigate the incidence and risk factors of late stroke in patients following left-heart valve replacement.
Main Methods:
- A prospective study followed 3,189 adult patients (3,576 valve replacement operations) for 20,096 patient-years.
- Bootstrapped survival analysis identified patient and valve-related factors influencing stroke incidence.
Main Results:
- Embolic strokes occurred at rates of 1.3-2.3% per year, with mitral mechanical valves having the highest incidence (2.3% +/- 0.4%).
- Independent risk factors included age >75, female gender, smoking, atrial fibrillation, coronary disease, and preoperative left ventricular dysfunction for mitral prostheses.
- Warfarin combined with aspirin or dipyridamole did not significantly reduce stroke risk in mechanical prosthesis recipients.
Conclusions:
- About 20% of patients with prosthetic valves experience an embolic stroke within 15 years post-replacement.
- Potentially modifiable risk factors include smoking cessation, choice of mitral mechanical prostheses, aortic tilting-disc valves, and timely mitral surgery before left ventricular dysfunction onset.
Background:
Stroke is a devastating complication in patients with prosthetic valves, but characterization of its late occurrence from a large cohort is lacking.
Methods:
Three thousand one hundred eighty-nine adult patients who underwent a total of 3,576 operations for left-heart valve replacement were managed with contemporary anticoagulation guidelines and prospectively followed in a dedicated clinic. Total follow-up was 20,096 patient years. Bootstrapped survival analysis was used to determine the impact of patient and valve related factors on the incidence of stroke.
Results:
Most strokes were embolic. Linearized embolic stroke rates were 1.3% +/- 0.2% per year for aortic bioprostheses, 1.4% +/- 0.2% per year for aortic mechanical valves, 1.3% +/- 0.3% per year for mitral bioprostheses, and 2.3% +/- 0.4% per year for mitral mechanical valves (p = 0.002, vs other implant types). Age more than 75 years, female gender, and smoking were independent risk factors after aortic and mitral valve replacement. Atrial fibrillation, coronary disease, and tilting-disc mechanical prostheses were independent predictors of embolic stroke after aortic valve replacement. Preoperative left ventricular (LV) dysfunction was an independent risk factor in patients with mitral prostheses. Primary operative indication, diabetes, redo status, or the presence of two prosthetic valves were not associated with an increased hazard. The addition of acetyl salicylic or dipyridamole to warfarin anticoagulation did not significantly lower embolic stroke risk in patients with mechanical prostheses.
Conclusions:
Approximately 20% of patients with valve prostheses have an embolic stroke by 15 years after valve replacement. Some risk factors such as the avoidance of smoking, mitral mechanical prostheses, aortic tilting-disc valves, and proceeding to mitral surgery before LV dysfunction occurs are potentially modifiable.
More Related Videos
Related Concept Videos
Mitral Valve Prolapse I: Introduction
Mitral Stenosis I: Introduction
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral Stenosis III: Medical Management
Aortic Regurgitation I: Introduction
Aortic Regurgitation III: Medical Management

